GenomeWeb

Enzo

Mar 11, 2014

Enzo Biochem Posts 3 Percent Revenue Gain for Q2

NEW YORK (GenomeWeb News) – Enzo Biochem reported after the close of the market Tuesday that its second quarter revenues increased 3 percent year over year, with growth posted for both its life sciences products and clinical lab services.

Feb 18, 2014

Enzo to Market Nuclea's Metastatic Breast Cancer Dx

NEW YORK (GenomeWeb News) – Enzo Clinical Labs and Nuclea Biotechnologies have entered into an agreement to market Nuclea's non-invasive HER-2/neu serum test for monitoring metastatic breast cancer, Enzo Biochem announced today.

Jan 06, 2014

Federal Court Awards Enzo Additional $12.4M Related to IP Suit Against Life Tech

NEW YORK (GenomeWeb News) – Enzo Biochem today said that a federal court has awarded the firm an additional $12.4 million in prejudgment interest in connection with a November 2012 jury verdict which found that Life Technologies infringed Enzo's patents.

Dec 11, 2013

Enzo Q1 Revenues up 6 Percent, Reaches CDx Deal with Flagship Bio

NEW YORK (GenomeWeb News) – Enzo Biochem reported after the close of the market yesterday a 6 percent drop in its FY 2014 revenues year over year.

Oct 29, 2013

Enzo Biochem to Market Sequenom's MaterniT21 Plus Test

NEW YORK (GenomeWeb News) – Enzo Biochem today said that it has signed an agreement to market Sequenom's MaterniT21 Plus test service in the northeast US.

Oct 17, 2013

IP Watch: Bio-Rad, Grifols Therapeutics, Samsung, Life Tech, Eiken, and Enzo Win US Patents

Premium

Bio-Rad Laboratories has been awarded US Patent No. 8,560,247, "Multi-stage, regression-based PCR analysis system."
Jeffrey Lerner is named as the inventor.

Oct 15, 2013

IP Roundup: CalTech, Maven Technologies, Cancer Genetics, Fujifilm, Enzo Life Sciences

Premium

The California Institute of Technology of Pasadena has received US Patent No. 8,557,199, "Self-powered microfluidic devices, methods and systems." The claimed device consists of microfluidic channels and a pressure source for pumping reagents through the channels.

Oct 15, 2013

Enzo Q4 Revenues Narrow 12 Percent

NEW YORK (GenomeWeb News) – Enzo Biochem reported after the close of the market on Tuesday a 12 percent drop in total revenues for its fiscal fourth quarter.

Aug 05, 2013

Federal Court Upholds $48.6M Award Against Life Tech

NEW YORK (GenomeWeb News) – A federal court has upheld a jury verdict which awarded Enzo Biochem $48.6 million after finding that Life Technologies has infringed Enzo's patents.

Aug 02, 2013

Enzo Files Shelf Registration to Offer up to $68M in Securities

NEW YORK (GenomeWeb News) – Enzo Biochem has filed a shelf registration to separately offer up to $50 million of its securities and another $18 million of its common stock.

Breaking News

The Scan

Working Out the Effect

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Increased Genetic Privacy in Florida

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

Attention-Grabbing in Two Ways

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

Nature Papers Describe CRISPR Plant Editing Methods, DNA-PAINT Improvements, More

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.

Menu